|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.840 USD | -10.70% |
|
+15.35% | +71.86% |
| 07-14 | Cumberland Pharmaceuticals Inc. announces an Equity Buyback for $5 million worth of its shares. | CI |
| 07-13 | Cumberland Pharmaceuticals Announces Special Dividend, Payable on July 31, 2026 | CI |
| Market Cap | 102M 89.68M 82.75M 76.25M 144M 9.87B 147M 987M 389M 4.83B 385M 376M 16.64B | P/E 2024 |
-5.14x | P/E 2025 | -20.8x |
|---|---|---|---|---|---|
| Enterprise Value | 101M 88.57M 81.73M 75.31M 142M 9.74B 145M 975M 384M 4.77B 380M 372M 16.44B | EV / Sales 2024 |
0.95x | EV / Sales 2025 | 1.31x |
| Free-Float |
57.09% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cumberland Pharmaceuticals Inc.
| 1 day | -10.70% | ||
| 1 week | +15.35% | ||
| Current month | +5.56% | ||
| 1 month | +19.58% | ||
| 3 months | +111.76% | ||
| 6 months | +47.10% | ||
| Current year | +71.86% |
| 1 week | 5.84 |  | 8.09 |
| 1 month | 5.5 | | 8.09 |
| Current year | 2.69 | | 8.09 |
| 1 year | 1.85 | | 8.09 |
| 3 years | 1.04 | | 8.09 |
| 5 years | 1.04 | | 8.09 |
| 10 years | 0 | | 8.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 67 | 07/01/1999 |
John Hamm
DFI | Director of Finance/CFO | 70 | 17/05/2021 |
Shayla Simpson
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CHM | Chairman | 67 | 07/01/1999 |
| Director/Board Member | 74 | 10/09/2010 | |
James Jones
BRD | Director/Board Member | 78 | 01/01/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/03/26 | Free | Responsable ventes & marketing | 3,000 | 0.0201% | ||
| 18/03/26 | Free | Director | 1,800 | 0.0120% | ||
| 18/03/26 | Free | Chief Executive Officer | 100,000 | 0.6686% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.70% | +15.35% | +112.42% | +341.29% | 102M | |
| +0.85% | -0.80% | +52.79% | +161.33% | 1,051B | |
| +1.23% | -1.53% | +54.58% | +59.08% | 609B | |
| +0.04% | +2.58% | +34.47% | +86.33% | 450B | |
| +0.78% | -0.71% | +29.28% | +24.10% | 330B | |
| +1.41% | +0.58% | +35.44% | +40.67% | 284B | |
| -0.27% | -1.87% | +22.34% | +22.51% | 263B | |
| -1.76% | +2.37% | -20.43% | -38.00% | 223B | |
| -1.42% | +0.80% | +24.27% | +57.50% | 198B | |
| -1.48% | +3.43% | +24.08% | +71.67% | 167B | |
| Average | -1.13% | +2.02% | +36.92% | +82.65% | 357.52B | |
| Weighted average by Cap. | +0.37% | +0.02% | +37.51% | +79.64% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 37.87M 33.14M 30.58M 28.17M 53.06M 3.65B 54.37M 365M 144M 1.79B 142M 139M 6.15B | 44.52M 38.96M 35.95M 33.12M 62.38M 4.29B 63.92M 429M 169M 2.1B 167M 164M 7.23B |
| Net income | -6.48M -5.67M -5.23M -4.82M -9.08M -624M -9.3M -62.4M -24.6M -306M -24.33M -23.8M -1.05B | -2.84M -2.48M -2.29M -2.11M -3.97M -273M -4.07M -27.31M -10.77M -134M -10.65M -10.42M -461M |
| Net Debt | 2.61M 2.28M 2.11M 1.94M 3.65M 251M 3.74M 25.12M 9.9M 123M 9.79M 9.58M 424M | -1.26M -1.11M -1.02M -941K -1.77M -122M -1.82M -12.17M -4.8M -59.61M -4.75M -4.64M -205M |
Employees
93
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | $6.840 | -10.70% | 239,781 |
| 16/07/26 | $7.660 | -1.79% | 107,228 |
| 15/07/26 | $7.800 | +11.67% | 106,081 |
| 14/07/26 | $6.985 | +6.80% | 121,914 |
| 13/07/26 | $6.540 | +10.29% | 336,562 |
- Stock Market
- Stocks
- CPIX Stock
Select your edition
All financial news and data tailored to specific country editions
